Rearrangements of MYC stemming from microhomology-mediated end joining were located by sequencing data in 36% of patients newly diagnosed with multiple myeloma and resulted in increased expression of c-myc and PVT1 (73). This evidence concerns the gene MYC and plasma cell myeloma.